Advertisement
Advertisement
U.S. Markets closed
Advertisement
Advertisement
Advertisement
Advertisement

PROCEPT BioRobotics Corporation (PRCT)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
20.76-0.09 (-0.43%)
At close: 04:00PM EST
20.76 0.00 (0.00%)
After hours: 04:00PM EST
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close20.85
Open20.65
Bid18.00 x 800
Ask24.21 x 1100
Day's Range20.00 - 21.17
52 Week Range20.00 - 47.73
Volume271,886
Avg. Volume179,943
Market Cap902.994M
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)-8.49
Earnings DateNov 04, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est49.00
  • Insider Monkey

    Hedge Funds Are Piling Into PROCEPT BioRobotics Corporation (PRCT)

    Many prominent investors, including Warren Buffett, David Tepper and Stan Druckenmiller, have been cautious regarding the current bull market and missed out as the stock market reached another high in recent weeks. On the other hand, technology hedge funds weren’t timid and registered double digit market beating gains. Financials, energy and industrial stocks initially suffered […]

  • GlobeNewswire

    PROCEPT BioRobotics Corp. Announces Preliminary Fourth Quarter and Fiscal Year 2021 Revenue

    REDWOOD CITY, Calif., Jan. 11, 2022 (GLOBE NEWSWIRE) -- PROCEPT® BioRobotics Corporation (Nasdaq: PRCT), a surgical robotics company focused on advancing patient care by developing transformative solutions in urology, today reported preliminary unaudited revenue for the fourth quarter and fiscal year ended December 31, 2021. Preliminary, Unaudited Revenue Highlights: Revenue for the fourth quarter of 2021 is expected to be in the range of $9.8 million to $10.1 million, compared to $3.2 million i

  • American City Business Journals

    Redwood City-based Procept Biorobotics is moving its HQ to San Jose

    The company makes a surgical robotic system for minimally invasive urologic surgery and its shares have dropped by 46% since it raised $164 million in a September IPO.

Advertisement
Advertisement